Welcome to Public Health On Call, a new podcast from the Johns Hopkins Bloomberg School of Public Health.

Our focus is the novel coronavirus.

I'm Josh Sharfstein, a faculty member at Johns Hopkins, and also a former secretary of Maryland's health department.

Our goal with this podcast is to bring evidence and experts to help you understand today's

news about the novel coronavirus and what it means for tomorrow.

If you have questions, you can email them to public health question at jhh.edu.

That's public health question at jh.h. That's public health question at jh.u.edu for future podcast episodes.

It's Friday, so today's the day for listener questions and answers.

Our respondent is one of our most popular question answerers, Dr. Amesh Adalja, senior scholar

at the Center for Health Security at the Johns Hopkins

Bloomberg School of Public Health. He's also a physician trained in internal medicine,

emergency medicine, infectious disease, and critical care. Let's listen.

Dr. Adalja, thank you so much for joining me again.

Let me just start with a general question.

What have we learned recently about the novel coronavirus that is worth mentioning to our listeners?

It seems like every day we learn a whole bunch of new things about it.

So what we're learning in the last

several weeks or since the last time we spoke were that there are different ways that people

get respiratory failure with this virus and it's not homogenous. So there are people in the ICU

that you have to use very different strategies on and we're learning about that on a day-to-day basis.

We're also learning about that there may be a link between an inflammatory syndrome and

children and this coronavirus.

...